COVID vaccine materials at J&J Baltimore facility to be disposed of over contamination concerns

  • 📰 Newsweek
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 52%

United States Headlines News

United States Latest News,United States Headlines

FDA allowed two more batches of Johnson & Johnson's COVID-19 vaccine to dispatch but said because of the possibility of contamination, other batches should not be released. Additional batches are still under review.

A possible contamination at Johnson & Johnson's Baltimore factory required the company to toss out materials used to make the vaccine, the Associated Press reported.

The doses originated at an Emergent BioSolutions factory, known as Bayview, that is making the vaccine for J&J. Those doses would be the first from the factory approved for use. J&J doses that had been administered came from other plants. The problems forced J&J to import millions of doses from its factory in the Netherlands and to miss supply commitments.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

wow they're still pumping out the covid19 virus vaccine you would think they would at least attempt for the covid 21 virus

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 468. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Johnson & Johnson says FDA has extended shelf life of single-dose COVID vaccine by six weeksOriginal three-month expiration dates loomed at end of June. It’s better to get sick and trust drugs that have been around for years. These Vaccines are experimental. These vaccines are more dangerous than getting covid and getting Hydroxychoroquine also it is more effective against Covid-19 than the vaccines.
Source: MarketWatch - 🏆 3. / 97 Read more »

FDA tells Johnson & Johnson to toss 60 million Covid vaccine dosesThe doses were produced at a plant in Baltimore that was previously found to have contamination issues. Just letting you know they're busting you on facebook Just what in Baltimore isn't contaminated? Q: What do you call 60 million tossed doses of an experimental vaccine? A: A good start.
Source: YahooNews - 🏆 380. / 59 Read more »

FDA tells Johnson & Johnson to toss 60 million Covid vaccine dosesThe FDA has told Johnson & Johnson to discard about 60,000,000 doses of its Covid-19 vaccine that were produced at a troubled plant in Baltimore, according to 2 people familiar with the matter. matteroffacttv 60 million people waiting longer for vax.
Source: NBCNews - 🏆 10. / 86 Read more »

Moderna asks FDA to clear Covid vaccine for adolescents 12 to 17If approved, it would likely dramatically expand the number of Covid vaccine shots available to middle and high school students ahead of the next school year.
Source: CNBC - 🏆 12. / 72 Read more »

Moderna files for FDA authorization of Covid vaccine for 12 to 17-year-oldsModerna has filed for FDA emergency use authorization of its Covid-19 vaccine for kids ages 12 to 17, which could expand the number of shots available to middle and high school students across the country. NBC News’ Dr. John Torres has the latest. Is it an emergency for this age group range to be trying a vaccine that has no longitudinal study? nice A lot of pressure
Source: MSNBC - 🏆 469. / 51 Read more »

Moderna’s Covid-19 Vaccine Seeks FDA Authorization for Use in AdolescentsModerna asked the FDA to authorize expanding the use of its Covid-19 vaccine to people as young as 12. The application means Moderna’s shot could be cleared for use in the older children this summer. 157,076,436 of 174,054,973 global covid-19 CASES recovered. Covid-19 CASES recover because they have natural efficacious immunoglobulin. So find out if you're immunoglobulin efficacy POSITIVE. Ask which (IET) covid-19 immunoglobulin efficacy test is right for you. There's a deafening silence around discussing natural immunoglobulin efficacy. Allopathic medical leaders recognised this efficacy in asymptomatic super spreaders. Why won't front line allopathic experts investigate how asymptomatics' efficacious immunoglobulin repels covid-19?
Source: WSJ - 🏆 98. / 63 Read more »